CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project investigates how radiosensitizers and radioprotectors can enhance or inhibit radiation damage in cancer therapy. By studying the fundamental mechanisms of radiation interactions with DNA and specific compounds, the aim is to improve the effectiveness of radiotherapy while minimizing side effects.
Dramatically increasing cancer cases around the world call for extra research efforts to improve cancer therapies.
Radiation therapy or radiotherapy is one of the most common treatment methods. A way to enhance radiotherapy is inserting radiosensitizers (RSs) and radioprotectors (RPs) into the patients body. RSs in tumor cells make them more sensitive to radiation damage, allowing one to use reduced radiation doses, thus minimizing side effects.
In contrast, RPs inhibit the damage of healthy cel…
AARHUS UNIVERSITET
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
